The effect of green tea in the treatment of Alzheimer's disease

The effect of green tea consumption on markers of oxidative stress in Alzheimer's patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201402233684N5

Enrollment

Registered

2015-08-15

Start date

2014-04-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer. Other Alzheimer disease

Interventions

Intervention :Green tea,2 mg orally tablets, 2 times a day for 2 months.

Intervention :Green tea,2 mg orally tablets, 2 times a day for 2 months

Eligibility

Sex/Gender

All

Age

67 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Alzheimer's disease Inclusion Exclusion: Taking vitamin and antioxidant supplements; drugs interfering; inflammatory diseases; acute and chronic infectious disease; thalassemia; diabetes; hepatitis

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Malondialdehyde. Timepoint: Before intervention, 2 months after the end of intervention. Method of measurement: TBARS Method (spectrophotometry).;Total antioxidant capacity. Timepoint: Before intervention, 2 months after the end of intervention. Method of measurement: FRAP Method.;8-OH-2-deoxy-Guanosine. Timepoint: Before intervention, 2 months after the end of intervention. Method of measurement: ELISA.;Carbonyl. Timepoint: Before intervention, 2 months after the end of intervention. Method of measurement: Levin Method.	—

Measure

Time frame

Malondialdehyde. Timepoint: Before intervention, 2 months after the end of intervention. Method of measurement: TBARS Method (spectrophotometry).;Total antioxidant capacity. Timepoint: Before intervention, 2 months after the end of intervention. Method of measurement: FRAP Method.;8-OH-2-deoxy-Guanosine. Timepoint: Before intervention, 2 months after the end of intervention. Method of measurement: ELISA.;Carbonyl. Timepoint: Before intervention, 2 months after the end of intervention. Method of measurement: Levin Method.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHourolein Arab

Babol University of Medical Sciences

hourolein.arab@yahoo.com+98 11 3326 8605

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026